Novartis shines in plant power

Novartis (NYSE: NVS) has dedicated a 1-megawatt solar array attached to its Vacaville, CA, biopharmaceutical site. The company expects to meet 20 percent of the plant's power needs from the $7 million system, whose 4100 solar panels cover five acres. Novartis has solar systems at five other sites. Article

Suggested Articles

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.